The team from the Biomedical Research Institute focused on the 2CV-Bing Hydrogen Molecule formed into three groups to conduct research in different areas during the early stages of drug development.
The team formed by Han Hui and Ai Lixin focused on the most stable and promising area of research. They were working on substituting the human immune environment, a complex task. Still, they were specifically aiming to produce the 2CV-Bing Hydrogen Molecule to replace the dysfunctional immune environment, making it more targeted and progress somewhat inevitable.
It's like a highly complicated program aiming to implement a single functionality. There are always some redundant codes that can be removed.
Dai Tianqing's team focused on researching the immune response of vertebrate mammals to rod bacteria invasion. Their hope was to find clues for mass production of the 2CV-Bing Hydrogen Molecule or small proteins similar to it. Any such discovery would certainly be crucial.